TFB Advisors’s Gilead Sciences GILD Stock Holding History

TFB Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$335K	Sell	2,405 -386	-14%	-$54.1K	0.18%	135
2025 Q4	$343K	Sell	2,791 -35	-1%	-$4.25K	0.1%	227
2025 Q3	$335K	Sell	2,826 -1,531	-35%	-$174K	0.1%	225
2025 Q2	$483K	Buy	4,357 +80	+2%	+$8.51K	0.13%	185
2025 Q1	$479K	Sell	4,277 -164	-4%	-$16.9K	0.14%	173
2024 Q4	$410K	Sell	4,441 -4,956	-53%	-$446K	0.12%	196
2024 Q3	$788K	Buy	9,397 +116	+1%	+$8.85K	0.23%	100
2024 Q2	$637K	Sell	9,281 -1,274	-12%	-$85K	0.21%	107
2024 Q1	$691K	Buy	10,555 +3,534	+50%	+$272K	0.25%	92
2023 Q4	$569K	Buy	+7,021	New	+$546K	0.29%	82
2023 Q3	–	Sell	-11,499	Closed	-$886K	–	144
2023 Q2	$886K	Buy	11,499 +6,684	+139%	+$533K	0.39%	64
2023 Q1	$400K	Buy	4,815 +372	+8%	+$30.8K	0.3%	65
2022 Q4	$381K	Buy	+4,443	New	+$352K	0.32%	63

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

TFB Advisors's GILD Position: Q1 2026 in Review

TFB Advisors reduced its Gilead Sciences (GILD) stake by 14% in Q1 2026, selling an estimated $54.1K and leaving 2,405 shares worth $335K. The position accounts for 0.18% of the portfolio, ranked #135.

TFB Advisors first reported a position in GILD in Q4 2022 and has held it in 13 quarters since. The position peaked at $886K in Q2 2023. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

TFB Advisors held 2,405 shares of Gilead Sciences worth $335K as of Q1 2026.
TFB Advisors sold 386 Gilead Sciences shares in Q1 2026, an estimated $54.1K.
Gilead Sciences made up 0.18% of TFB Advisors's portfolio in Q1 2026, its #135 holding.
TFB Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 13 quarters since.
TFB Advisors's Gilead Sciences position peaked at $886K in Q2 2023.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on TFB Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.